I.C.O.N.is an international hair care products created by two industry experts from different cultures and continents joining together to form one forward-thinking company. It continues as a multi-dimensional commitment to green technology, liquid fashion and determined energy for all things beauty.
I.C.O.N. is proud to support the mission of STOP CANCER and joined forces in 2007, launching its worldwide campaign “Cure for a Cause” which donates a percentage of sales of Cure, a replenishing spray, to STOP CANCER.
The first recipient of the STOP CANCER I.C.O.N. “Cure for a Cause” Seed Grant was Richard J. Pietras
, M.D., Ph.D., Professor of Medicine at the UCLA David Geffen School of Medicine and the Director of the Stiles Program in Integrative Oncology at UCLA’s Jonsson Comprehensive Cancer Center. His research focuses largely on the biology and treatment of women’s cancers, with an aim toward translation of basic research findings “from the bench to the bedside.” Early on, he helped investigate HER-2 growth factor receptor
s which are crucial in the regulation of breast cancer cell growth and, in collaboration with Dr. Dennis Slamon (STOP CANCER Awardee), helped to develop the HER-2 antibody, Herceptin, the praised drug now used globally for some breast cancers. Recently, Dr. Pietras was recognized by his peers with a National Cancer Partnership Research Award and a UCLA Academic Senate Faculty Research Award. He feels STOP CANCER should be proud of its role in advancing cancer research and calls the organization “a vital part of the team.”
The second recipient of the STOP CANCER I.C.O.N. “Cure for a Cause” Seed Grant is Susan McCloskey, M.D.
who received the grant in 2012. Dr. McCloskey is Assistant Professor, Department of Radiation Oncology at UCLA and a Member of the JCCC Patients and Survivors Program Area. She is also a practicing physician at Ronald Reagan UCLA Medical Center, as well as at Santa Monica - UCLA Medical Center and Orthopedic Hospital. Dr. McCloskey’s research is centered on quality of care and quality of life, along with health technology and outcomes assessment.
In January 2013, I.C.O.N. was proud to present Arash Naeim, M.D., Ph.D with a STOP CANCER I.C.O.N. “Cure for a Cause” Seed Grant. Dr. Naeim is the UCLA Principal Investigator for the Athena Breast Health Network, a UC-wide initiative to improve the care of women from screening to diagnosis to treatment for breast cancer. His team is implementing an innovative quality improvement and registry project serving as the foundation and infrastructure support for several research studies.
Bogdan Pasaniuc, M.D.
was awarded the 2014 STOP CANCER I.C.O.N. Seed Grant. Dr. Pasaniuc is Assistant Professor in the Department of pathology and Laboratory Medicine with a joint appointment in the Department of Human Genetics at the David Geffen School of Medicine at UCLA.
His research employs bioinformatics to study population genetics with the goal of identifying novel risk factors for breast cancer.
The recipient of the 2015 STOP CANCER I.C.O.N. “Cure for a Cause” Seed Grant is Dr. Erica K. Sloan. Dr. Sloan’s research focuses upon the underlying mechanisms through which psychological stress may influence cancer progression. Her research aims to define the neural, inflammatory and tumor mechanisms for the effects of stress on metastasis, and to develop pharmacologic strategies to slow cancer progression. Dr. Sloan is an Assistant Adjunct Professor in the UCLA Semel Institute for Neuroscience and Human Behavior and is a member of the Cousins Center for psychoneuroimmunology, the UCLA Jonsson Comprehensive Cancer Center and the UCLA Aids Institute.
Andrea Hevener, Ph.D.
is the 2016 STOP CANCER I.C.O.N. "Cure for a Cause" Seed Grant recipient. Dr. Hevener and her research team have recently shown that a novel fat cell secreted factor promotes breast cancer cell growth and migration in culture and that this factor is elevated in circulation in obese women with breast cancer. The Hevener laboratory aims to identify novel strategies enhancing cellular metabolism in obese women to reduce breast cancer risk and recurrence.
I.C.O.N.’s commitment to helping find a cure for cancer remains strong, and it continues to be dedicated to helping STOP CANCER. It is why Cure is its cause.